摘要:
The present invention relates to replication-defective recombinant retrovirus capable of infecting human cells and carrying a vector construct which is capable of directing the expression of both: a. an MHC protein or modified form thereof and b. an antigen which is not an MHC protein or modified form thereof, said MHC protein or modified form thereof in cells infected with said retrovirus within a human or animal body being capable of presenting said antigen or a portion thereof so as to stimulate a cell-mediated immune response.
摘要:
The present invention relates to replication-defective recombinant retrovirus capable of infecting human cells and carrying a vector construct which is capable of directing the expression of both:
a. an MHC protein or modified form thereof and b. an antigen which is not an MHC protein or modified form thereof, said MHC protein or modified form thereof in cells infected with said retrovirus within a human or animal body being capable of presenting said antigen or a portion thereof so as to stimulate a cell-mediated immune response.
摘要:
The present invention relates to replication-defective recombinant retroviruses for therapeutic use. In particular, it relates to use of replication-defective recombinant retroviruses carrying a vector construct capable of expressing in human cells an enzyme which converts an agent with little or no cytotoxicity into a cytotoxic agent in the treatment of graft vs host disease.